Literature DB >> 12195022

A new name in thrombosis, ADAMTS13.

J Evan Sadler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12195022      PMCID： PMC129303          DOI： 10.1073/pnas.192448999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  29 in total

1.  Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen.

Authors:  Y Asada; A Sumiyoshi; T Hayashi; J Suzumiya; K Kaketani
Journal:  Thromb Res       Date:  1985-06-01       Impact factor: 3.944

2.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

3.  Thrombotic thrombocytopenic purpura associated with clopidogrel.

Authors:  C L Bennett; J M Connors; J M Carwile; J L Moake; W R Bell; S R Tarantolo; L J McCarthy; R Sarode; A J Hatfield; M D Feldman; C J Davidson; H M Tsai
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

4.  Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; L Rice; R Sarode; T W Chow; J L Moake
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

5.  Partial amino acid sequence of purified von Willebrand factor-cleaving protease.

Authors:  H E Gerritsen; R Robles; B Lämmle; M Furlan
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

6.  Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers.

Authors:  Maneesh Arya; Bahman Anvari; Gabriel M Romo; Miguel A Cruz; Jing-Fei Dong; Larry V McIntire; Joel L Moake; José A López
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

7.  ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family.

Authors:  T L Hurskainen; S Hirohata; M F Seldin; S S Apte
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

8.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

9.  Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

Authors:  B Savage; F Almus-Jacobs; Z M Ruggeri
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

10.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205
View more
  17 in total

1.  Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.

Authors:  Nataliya Mar; Antonio Mendoza Ladd
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

2.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 3.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Mutation G1629E Increases von Willebrand Factor Cleavage via a Cooperative Destabilization Mechanism.

Authors:  Camilo Aponte-Santamaría; Svenja Lippok; Judith J Mittag; Tobias Obser; Reinhard Schneppenheim; Carsten Baldauf; Frauke Gräter; Ulrich Budde; Joachim O Rädler
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

5.  Internal tension in a collapsed polymer under shear flow and the connection to enzymatic cleavage of von Willebrand factor.

Authors:  Matthias Radtke; Svenja Lippok; Joachim O Rädler; Roland R Netz
Journal:  Eur Phys J E Soft Matter       Date:  2016-03-22       Impact factor: 1.890

6.  Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.

Authors:  Kenji Nishio; Patricia J Anderson; X Long Zheng; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Multi-step binding of ADAMTS-13 to von Willebrand factor.

Authors:  H B Feys; P J Anderson; K Vanhoorelbeke; E M Majerus; J E Sadler
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

8.  Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.

Authors:  Thomas J Raife; Wenjing Cao; Bonnie S Atkinson; Bruce Bedell; Robert R Montgomery; Steven R Lentz; George F Johnson; X Long Zheng
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

9.  AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura.

Authors:  Sheng-Yu Jin; Juan Xiao; Jialing Bao; Shangzhen Zhou; J Fraser Wright; X Long Zheng
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

10.  Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactions.

Authors:  Camilo Aponte-Santamaría; Volker Huck; Sandra Posch; Agnieszka K Bronowska; Sandra Grässle; Maria A Brehm; Tobias Obser; Reinhard Schneppenheim; Peter Hinterdorfer; Stefan W Schneider; Carsten Baldauf; Frauke Gräter
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.